Simtomax, a novel point of care test for coeliac disease

Expert Opinion on Medical Diagnostics

Volumn 7, Issue 6, 2013, Pages 645-651

  Mooney, Peter D ^a   Kurien, Matthew ^a   Sanders, David S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Coeliac; Point of care; Serology; Simtomax

Indexed keywords

GLIADIN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

CELIAC DISEASE; DIAGNOSTIC ACCURACY; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; POINT OF CARE TESTING; PROTEIN BLOOD LEVEL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIMTOMAX;

AMBULATORY CARE; CELIAC DISEASE; GLIADIN; HEMATOLOGIC TESTS; HUMANS; IMMUNOGLOBULIN A; POINT-OF-CARE SYSTEMS;

EID: 84887281349     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2013.836179     Document Type: Review

References (36)

1. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119(1):234-42
2. Sanders DS, Patel D, Stephenson TJ, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003;15(4):407-13
3. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52(7):960-5
4. Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res 2010;10:105
5. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163(3):286-92
6. NICE. Coeliac Disease: Recognition and Assessment of Coeliac Disease. 2009. Available from: www.nice.org.uk/ CG86 [Accessed 23 January 2012]
7. Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4(6):713-17
8. Nemec G, Ventura A, Stefano M, et al. Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol 2006;101(7):1597-600
9. Raivio T, Korponay-Szabo I, Collin P, et al. Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies. Dig Liver Dis 2007;39(12):1057-63
10. Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006;24(1):147-54
11. Korponay-Szabo IR, Raivio T, Laurila K, et al. Coeliac disease case finding and diet monitoring by point-of-care testing. Aliment Pharmacol Ther 2005;22(8):729-37
12. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007;335(7632):1244-7
13. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54(1):136-60
14. Dickey W, McMillan SA, McCrum EE, Evans AE. Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening. Eur J Gastroenterol Hepatol 1997;9(6):559-62
15. George D, Hui L, Rattehalli D, et al. Small bowel and nutrition section free papers: the role of near patient coeliac serology testing in the follow-up of patients with coeliac disease. Gut 2011;60:abstract
16. Aleanzi M, Demonte AM, Esper C, et al. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001;47(11):2023-8
17. Niveloni S, Sugai E, Cabanne A, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 2007;53(12):2186-92
18. Osman AA, Gunnel T, Dietl A, et al. B cell epitopes of gliadin. Clin Exp Immunol 2000;121(2):248-54
19. Schwertz E, Kahlenberg F, Sack U, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004;50(12):2370-5
20. Sugai E, Vazquez H, Nachman F, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006;4(9):1112-17
21. Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010;44(3):186-90
22. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31(1):73-81
23. Giersiepen K, Lelgemann M, Stuhldreher N, et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 2012;54(2):229-41
24. Mozo L, Gomez J, Escanlar E, et al. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J Pediatr Gastroenterol Nutr 2012;55(1):50-5
25. Harrison E, Li KK, Petchey M, et al. Selective measurement of anti-tTG antibodies in coeliac disease and IgA deficiency: an alternative pathway. Postgrad Med J 2013;89(1047):4-7
26. Korponay-Szabo IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 2003;52(11):1567-71
27. Lenhardt A, Plebani A, Marchetti F, et al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis 2004;36(11):730-4
28. Benkebil F, Combescure C, Aubert V, et al. Validation of a new point-of-care test for a universal screening of celiac disease [abstract]. J Pediatr Gastroenterol Nutr 2009;48(Suppl 3):PG1-12
29. Benkebil F, Duvanel C, Combescure C, et al. Assessing accuracy of interpretation of a rapid celiac assay in a ward setting [abstract]. J Pediatr Gastroenterol Nutr 2010;50(Suppl 2):PO-G-172
30. Mizen L. Simtomax: a new screening tool for coeliac disease. Br J Health Manag 2012;18(1):27-32
31. Bienvenu F, Besson Duvanel C, Seignovert C, et al. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Eur J Gastroenterol Hepatol 2012;24(12):1418-23
32. Pichler J, Zilbauer M, Torrente F, et al. Feasibility of a finger prick-based selftesting kit in first- and second-degree relatives of children with coeliac disease. World J Gastroenterol 2011;17(14):1840-3
33. Mooney PD, Evans KE, Singh S, Sanders DS. Treatment failure in coeliac disease: a practical guide to investigation and treatment of non-responsive and refractory coeliac disease. J Gastrointestin Liver Dis 2012;21(2):197-203
34. Errichiello S, Esposito O, Di Mase R, et al. Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. J Pediatr Gastroenterol Nutr 2010;50(1):54-60
35. Biagi F, Andrealli A, Bianchi PI, et al. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br J Nutr 2009;102(6):882-7
36. Zanchi C, Ventura A, Martelossi S, et al. Rapid anti-transglutaminase assay and patient interview for monitoring dietary compliance in celiac disease. Scand J Gastroenterol 2013;48(6):764-6